We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Haleon Plc | LSE:HLN | London | Ordinary Share | GB00BMX86B70 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.90 | 0.87% | 334.40 | 334.70 | 334.80 | 336.00 | 330.80 | 332.70 | 24,166,169 | 16:35:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Offices-holdng Companies,nec | 11.3B | 1.05B | 0.1136 | 29.47 | 30.92B |
TIDMHLN
RNS Number : 6001Z
Haleon PLC
16 May 2023
16 May 2023
HALEON PLC
("Haleon" or "the Company")
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BMX86B70
Issuer Name
Haleon plc
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Glaxo Group Limited
City of registered office (if applicable)
Brentford
Country of registered office (if applicable)
United Kingdom
Name City of registered office Country of registered office GlaxoSmithKline Holdings Limited Brentford England =========================== ============================== GlaxoSmithKline Finance plc Brentford England =========================== ==============================
4. Details of the shareholder
Name City of registered office Country of registered office Vidacos Nominees Limited London England =========================== ==============================
5. Date on which the threshold was crossed or reached
12-May-2023
6. Date on which Issuer notified
15-May-2023
7. Total positions of person(s) subject to the notification obligation
% of voting rights % of voting rights Total of both in % Total number of attached to shares through financial (8.A + 8.B) voting rights held (total of 8.A) instruments (total in issuer of 8.B 1 + 8.B 2) Resulting situation on the date on which threshold was crossed or reached 2.850000 0.000000 2.850000 262727073 ====================== ====================== ====================== ====================== Position of previous notification (if applicable) 5.440000 0.000000 5.440000 ====================== ====================== ====================== ======================
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares Number of direct Number of indirect % of direct voting % of indirect voting ISIN code(if possible) voting rights (DTR5.1) voting rights rights (DTR5.1) rights (DTR5.2.1) (DTR5.2.1) GB00BMX86B70 262727073 2.850000 ====================== ====================== ====================== ====================== Sub Total 8.A 262727073 2.850000% ============================================== ==============================================
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial Expiration date Exercise/conversion period Number of voting rights % of voting rights instrument that may be acquired if the instrument is exercised/converted Sub Total 8.B1 =========================================== ========================= ==================
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial Expiration date Exercise/conversion Physical or cash Number of voting % of voting rights instrument period settlement rights Sub Total 8.B2 ========================================================= =================== ==================
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate controlling Name of controlled % of voting rights if % of voting rights Total of both if it person undertaking it equals or is through financial equals or is higher higher than the instruments if it than the notifiable notifiable threshold equals or is higher threshold than the notifiable threshold GSK plc 2.850000 2.850000% ===================== ===================== ====================== GlaxoSmithKline GSK plc Holdings Limited 2.850000 2.850000% ======================= ===================== ===================== ====================== GlaxoSmithKline GSK plc Finance plc 2.850000 2.850000% ======================= ===================== ===================== ====================== GSK plc Glaxo Group Limited 2.850000 2.850000% ======================= ===================== ===================== ======================
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
GSK plc is making this notification on behalf of Glaxo Group Limited, GlaxoSmithKline Finance plc and GlaxoSmithKline Holdings Limited.
This notification relates to the sale by Glaxo Group Limited (a wholly-owned subsidiary of GSK plc and the holder of other external minority interests of the GSK group) of a portion of its interest in Haleon plc. A separate notification has also been submitted today by GSK plc in respect of its own notification obligation.
Glaxo Group Limited holds its shares in Haleon plc via a custodian, Vidacos Nominees Limited (as detailed in section 4 above), which holds the legal title to those shares on Glaxo Group Limited's behalf pursuant to a custody arrangement.
12. Date of Completion
15-May-2023
13. Place Of Completion
London, England
Amanda Mellor, Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLUNRAROOUVAAR
(END) Dow Jones Newswires
May 16, 2023 09:00 ET (13:00 GMT)
1 Year Haleon Chart |
1 Month Haleon Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions